Sign In
Buy TLRY
$4.46
+0.0400 (+0.90%)
At Close: Jul 13, 2026
Tilray Brands to Announce Fourth Quarter and Fiscal Year 2026 Financial Results on July 28, 2026
05:00pm, Monday, 13'th Jul 2026
NEW YORK and LONDON and LEAMINGTON, Ontario, July 13, 2026 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packag
BrewDog Waterloo to Host England's Biggest Pub Watch Party for Blockbuster Semifinal
09:41am, Monday, 13'th Jul 2026
England's biggest pub comes alive for a blockbuster semifinal, delivering the atmosphere, the passion and an unforgettable football watch party as fans rally behind England England's biggest pub comes
Tilray Medical Announces Commercial Launch of Medical Cannabis in Panama, Expanding Patient Access Across Latin America
04:00pm, Thursday, 09'th Jul 2026
Launch of Tilray Medical's first medical cannabis product in Panama strengthens the company's international footprint and supports broader access to regulated cannabinoid-based medicines Launch of Til
Breckenridge Distillery Launches Breck Vodka Seltzer, a Crisp New Ready-to-Drink Line Born in the Rockies
01:00pm, Thursday, 09'th Jul 2026
The Award-Winning Colorado Craft Distillery Enters the Vodka Seltzer Category with Four Refreshing Flavors at 5% ABV The Award-Winning Colorado Craft Distillery Enters the Vodka Seltzer Category with
Tilray Brands, Inc. (TLRY) Declines More Than Market: Some Information for Investors
07:16pm, Tuesday, 07'th Jul 2026
Tilray Brands, Inc. (TLRY) closed the most recent trading day at $4.31, moving 1.6% from the previous trading session.
Tilray's Stock Is Down Over 50% This Year. Has It Become a Bargain Buy?
07:00pm, Tuesday, 07'th Jul 2026
Tilray's business has gotten bigger over the years, but that's largely due to acquisitions. The company continues to struggle with profitability.
Why Tilray Stock Tumbled Last Month
04:39pm, Tuesday, 07'th Jul 2026
It also announced the latest in a series of acquisitions. And it was the subject of an analyst price target cut.
Should You Buy Tilray Stock Before July 15?
04:15pm, Tuesday, 07'th Jul 2026
Long-term reform matters more than short-term headlines. Strong liquidity gives Tilray valuable financial flexibility.
Top Canadian Marijuana Stock Picks For Investors Today
12:42pm, Monday, 06'th Jul 2026
As the cannabis sector continues to grow, it has marijuana stock investors seeing green. There has been a long, volatile battle for most of the time cannabis companies have been publicly traded. Even
Is Tilray a Textbook Value Trap -- or the Most Undervalued Cannabis Stock on the Market?
08:30pm, Thursday, 02'nd Jul 2026
Tilray hopes that several ongoing developments will help it rebound. But the company's outlook remains highly uncertain.
TLRY Plans Strategic Medical Cannabis Expansion: Time to Buy or Sell?
09:25am, Thursday, 02'nd Jul 2026
Tilray expands its medical cannabis strategy with HelloMD, adding virtual patient access as investors weigh growth potential against ongoing profitability challenges.
A Revolutionary Technology Narrative Has Surged—Don't Take the Bait
08:05am, Thursday, 02'nd Jul 2026
Although the growth rates coming out of the quantum computing segment look genuinely spectacular on paper, Wall Street has stood on this exact ledge before, and the fall has never been gentle.
Tilray Brands, Inc. (TLRY) Suffers a Larger Drop Than the General Market: Key Insights
07:01pm, Wednesday, 01'st Jul 2026
The latest trading day saw Tilray Brands, Inc. (TLRY) settling at $4.43, representing a -1.34% change from its previous close.
Breckenridge Distillery Earns Double Gold for Rum Cask Finish at New York International Spirits Competition
02:00pm, Tuesday, 30'th Jun 2026
BRECKENRIDGE, Colo. , June 30, 2026 (GLOBE NEWSWIRE) -- Breckenridge Distillery, one of the most-awarded craft distilleries in the U. S. and a subsidiary of Tilray Brands, Inc. (NASDAQ: TLRY and TSX:
Cannabis's 280E Tax Trap May Finally Break. We've Heard That Before.
10:45am, Tuesday, 30'th Jun 2026
While cannabis investors finally have an expedited DEA administrative hearing on the calendar and a fresh Schedule III pathway in motion, Wall Street has stood at this exact intersection before.
